Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 3 3Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Dysplasia 2Uterine Cervical Neoplasms 1Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

Paclitaxel 150Carboplatin 110Cisplatin 94Bevacizumab 42Topotecan 39Gemcitabine 38liposomal doxorubicin 34Radiotherapy 29Doxorubicin 27Brachytherapy 26Taxes 24pembrolizumab 20olaparib 20Drug Therapy 20Hyperthermic Intraperitoneal Chemotherapy 16Chemotherapy, Adjuvant 16human papillomavirus vaccine, L1 type 16, 18 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Docetaxel 13Neoadjuvant Therapy 12Platinum 10niraparib 9Radiation 91,2-diaminocyclohexaneplatinum II citrate 9Vaccines, Synthetic 8Surgical Procedures, Operative 8atezolizumab 7Specimen Handling 7Papillomavirus Vaccines 7Letrozole 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Colposcopy × Gynecologic × Clear all
NCT01131312 2018-11-20

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
5,060 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
2 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡